Press release
Pulmonary Arterial Hypertension Market worth $14.20 billion by 2030, growing at a CAGR of 6.57% - Exclusive Report by 360iResearch
Pulmonary Arterial Hypertension Market | 360iResearch
Request Sample Copy of this Report @ https://www.360iresearch.com/library/intelligence/pulmonary-arterial-hypertension?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Market Segmentation & Coverage:
This research report categorizes the Pulmonary Arterial Hypertension Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Drug Class, market is studied across Calcium Channel Blocker, Endothelin Receptor Antagonists, Phosphodiesterase 5, and Prostacyclin & Prostacyclin Analog. The Phosphodiesterase 5 is projected to witness significant market share during forecast period.
Based on Distribution, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy. The Retail Pharmacy is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Pulmonary Arterial Hypertension Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Pulmonary Arterial Hypertension Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Pulmonary Arterial Hypertension Market, highlighting leading vendors and their innovative profiles. These include Actelion Pharmaceuticals US, Inc., Arena Pharmaceuticals, Bayer AG, Bristol-Myers Squibb Company, CMP Pharma, Inc., Gilead Sciences, Inc., GlaxoSmithKline PLC, Gossamer Bio, Inc., Johnson & Johnson Services, Inc., Merck & Co. Inc., Novartis AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., United Therapeutics Corporation, and Viatris Inc..
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Pulmonary Arterial Hypertension Market, by Drug Class
7. Pulmonary Arterial Hypertension Market, by Distribution
8. Americas Pulmonary Arterial Hypertension Market
9. Asia-Pacific Pulmonary Arterial Hypertension Market
10. Europe, Middle East & Africa Pulmonary Arterial Hypertension Market
11. Competitive Landscape
12. Competitive Portfolio
13. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Pulmonary Arterial Hypertension Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Pulmonary Arterial Hypertension Market?
3. What is the competitive strategic window for opportunities in the Pulmonary Arterial Hypertension Market?
4. What are the technology trends and regulatory frameworks in the Pulmonary Arterial Hypertension Market?
5. What is the market share of the leading vendors in the Pulmonary Arterial Hypertension Market?
6. What modes and strategic moves are considered suitable for entering the Pulmonary Arterial Hypertension Market?
Read More @ https://www.360iresearch.com/library/intelligence/pulmonary-arterial-hypertension?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Arterial Hypertension Market worth $14.20 billion by 2030, growing at a CAGR of 6.57% - Exclusive Report by 360iResearch here
News-ID: 3233231 • Views: …
More Releases from 360iResearch
Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - …
The "Satellite IoT Market by Service Type (Direct to Satellite Services, Sat-IoT Backhaul Services), Frequency Band (Ka-band, Ku-band, L-band), End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
The Global Satellite IoT Market to grow from USD 1.57 billion in 2023 to USD 5.73 billion by 2030, at a CAGR of 20.30%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/satellite-iot?utm_source=openpr&utm_medium=referral&utm_campaign=sample
The utilization of satellite IoT is significantly growing across various regions,…
Laboratory Chemicals Market worth $40.97 billion by 2030, growing at a CAGR of 8 …
The "Laboratory Chemicals Market by Type (Biochemistry, Carbohydrate Analysis, Cell/Tissue Culture), Application (Academia/Educational, Government, Healthcare & Pharmaceutical) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
The Global Laboratory Chemicals Market to grow from USD 22.41 billion in 2023 to USD 40.97 billion by 2030, at a CAGR of 8.99%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/laboratory-chemicals?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Laboratory chemicals include acids, solvents, reagents, and analytical standards for testing and experiments. Laboratory…
Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - …
The "Satellite IoT Market by Service Type (Direct to Satellite Services, Sat-IoT Backhaul Services), Frequency Band (Ka-band, Ku-band, L-band), End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
The Global Satellite IoT Market to grow from USD 1.57 billion in 2023 to USD 5.73 billion by 2030, at a CAGR of 20.30%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/satellite-iot?utm_source=openpr&utm_medium=referral&utm_campaign=sample
The utilization of satellite IoT is significantly growing across various regions,…
Disposable Surgical Gloves Market worth $12.56 billion by 2030, growing at a CAG …
The "Disposable Surgical Gloves Market by Product (Natural Rubber Gloves, Nitrile Disposable Gloves, Vinyl Disposable Gloves), Form (Powdered Gloves, Powdered-Free Gloves), Distribution Channel, End-Users - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
The Global Disposable Surgical Gloves Market to grow from USD 6.51 billion in 2023 to USD 12.56 billion by 2030, at a CAGR of 9.84%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/disposable-surgical-gloves?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Disposable surgical gloves are used by…
More Releases for Pulmonary
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Embolism - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Pulmonary Embolism - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Embolism - Pipeline Review, H2 2017, provides an overview of the Pulmonary Embolism (Cardiovascular) pipeline landscape.
Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the lung, usually by a blood…
Pulmonary Drugs 2024 Market Research Report
Global Pulmonary Drugs Market: Snapshot
The global pulmonary drugs market has been the key area of focus and the most crucial market for the healthcare industry in the last couple of years. However, the market is expected to witness a significant decline over the forecast period with a -6.3% CAGR from 2016 to 2024. The market is anticipated to fall to US$28,082.1 mn from a valuation of US$48,039.7 mn in…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
